A Simplified Approach to the Management of Patients with
CHRONIC HEPATITIS C VIRAL INFECTIONS

THIS PROGRAM CONTAINS:

• Who and How to Screen for HCV Infections
• Explanations of Laboratory Results
• What the Patient Should Know About HCV (natural history, transmission, diet, activity, alcohol, etc.)
• Extrahepatic Manifestations
• Indications for Treatment
• Contraindications to Treatment
• Patients Most Likely to Respond to Treatment
• Treatment (dosage, monitoring, side effects)
• Data Entry / Display (graph and/or table format)
• Interpreting Responses to Treatment
• Recommendations for Long-term Follow-up
• Guidelines for Prevention
• Prognosis

Prepared by:
Gerald Y. Minuk M.D. F.R.C.P.(C)
Professor of Medicine and Pharmacology
Director, Liver Diseases Unit and
Liver Diseases Research Laboratory,
University of Manitoba, Health Sciences Centre,
Winnipeg, Manitoba, Canada

Geoffrey M. Dusheiko M.D. F.C.P.(SA) F.R.C.P.
Reader in Medicine and Consultant Physician
Hepatobiliary and Liver Transplantation Unit
Royal Free Hospital and School of Medicine,
London, United Kingdom

Anna S. F. Lok M.D. M.R.C.P.   F.R.C.P.
Professor of Medicine
Director of Clinical Hepatology
University of Michigan Medical Center
Ann Arbor, Michigan, U.S.A.

Dr. Mauricio Lisker-Melman
Associate Professor of Medicine
Director, Hepatitis Laboratory
Universidad Nacional de Mexico
Instituto Nacional de la Nutricion
Salvador Zubiran
Mexico City, Mexico

W. Graham E. Cooksley M.D. M.R.A.C.P. F.R.A.C.P.
Professor of Biochemistry
Royal Brisbane Hospital
Director, Clinical Research Center
University of Queensland
Brisbane, Australia